Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
批准号:
10667986
负责人:
Lorraine Zvichapera Mutsvunguma
金额:
$34.55万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2025-01-31
关键词:
AIDS with Kaposi&aposs sarcomaAnimal ExperimentsAnimal ModelAnimalsAntibodiesAntibody ResponseB-LymphocytesBiochemicalBlood PressureCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCallithrixCallithrix jacchus jacchusCancer EtiologyCase StudyCell CountCellsChemicalsCollaborationsComplexDefectDevelopmentDoseDropsDrug KineticsEtiologyExcisionExhibitsFrequenciesHIVHIV SeronegativityHIV/AIDSHerpesviridae InfectionsHumanHuman Herpesvirus 8ImmuneImmune responseImmune systemImmunocompetentImmunocompromised HostImmunologic Deficiency SyndromesImmunosuppressionIn VitroIndividualInfectionIntravenousJapanKaposi SarcomaLaboratoriesLesionLightMalignant NeoplasmsMediatingMethodsModelingMonkeysMonoclonal AntibodiesMusNewly DiagnosedPathogenesisPeripheral Blood Mononuclear CellPersonsPlayPopulationPredispositionPrimatesPropertyReagentResearchResolutionResourcesRoleSerumSplenocyteT cell reconstitutionT cell responseT-Cell DepletionT-LymphocyteTacrolimusToxic effectUreaViral Load resultVirusVirus DiseasesWisconsincell mediated immune responsecytotoxic CD8 T cellsfrontierhigh riskhuman pathogenimmunosuppressedimprovedin vivoin vivo Modelmurine monoclonal antibodynonhuman primateoral infectionpermissivenessreconstitutionrespiratoryresponseside effectskin lesiontool
中文摘要
项目摘要
卡波西肉瘤相关疱疹病毒(KSHV)是几种人类恶性肿瘤的病原体,包括
卡波西肉瘤(KS)。KS是最常见的KSHV相关恶性肿瘤,报告了> 44,000例新病例
每年在全球范围内。最易感染KSHV/KS的人群是免疫功能低下的个体,
感染艾滋病病毒的人。艾滋病毒/艾滋病感染者患KS的风险高于
艾滋病毒阴性个体。适应性T细胞免疫应答,特别是CD 4+和CD 8 + T细胞,已经被广泛应用。
显示在KSHV感染和随后的KS发病机制中起关键作用。虽然,
已观察到CD 4+和CD 8 + T细胞水平与KS发展,但尚未发现这种关系。
由于缺乏合适的动物模型,最近的发展共同的
绒猴(Callithrix jacchus)作为对KSHV感染易感的非人灵长类动物(NHP)模型,
能够在免疫抑制下发展KS样病变开辟了新的领域,
免疫细胞在KS发展中的作用。因此,我们的目标是确定减少的CD 4+和
在绒猴NHP模型中持续KSHV感染和随后KS发病机制中的CD 8 + T细胞水平
抗-CD 4和抗-CD 8单克隆抗体(mAb)已用于耗尽T细胞并诱导T细胞凋亡。
在小鼠和NHP动物模型中的免疫抑制,使得能够研究CD 4 +/CD 8 + T细胞在控制
几种病毒的复制。为了避免在给药时对鼠mAb产生任何不良反应,
我们将嵌合(鼠-绒猴)抗CD 4/CD 8单克隆抗体,并表征其生化和
在体外和小鼠体内的药代动力学特性,然后我们将确定抗体介导的T细胞
对各种免疫细胞群体的消耗(目的1)。然后我们将挑战免疫抑制的绒猴
与KSHV.219病毒感染,并确定抗体介导的CD 4+和/或CD 8 + T细胞耗竭的程度,
细胞使KSHV持续感染和KS发病机制免疫受损的绒猴(目的2)。的
本计画的成功完成将验证普通绒猴作为了解病因的工具
揭示了CD 4+和/或CD 8 + T细胞耗竭在持续性KSHV中的关键作用
感染和随后KS发病机制。
英文摘要
PROJECT ABSTRACT
Kaposi sarcoma-associated herpesvirus (KSHV) is the causative agent of several human malignancies including
Kaposi sarcoma (KS). KS is the most common KSHV-associated malignancy, with >44,000 new cases reported
worldwide each year. The population most vulnerable to KSHV/KS are immunocompromised individuals such
as people infected with HIV. Individuals with HIV/AIDS have a higher risk of developing KS when compared to
HIV-negative individuals. The adaptive T cell immune response, especially CD4+ and CD8+ T cells, has been
shown to play a crucial role in KSHV infection and subsequent KS pathogenesis. Although correlations between
CD4+ and CD8+ T cell levels and KS development have been observed, this relationship has not been
experimentally validated due to the lack of a suitable animal model. The recent development of the common
marmoset (Callithrix jacchus) as a non-human primate (NHP) model that is susceptible to KSHV infection and
capable of developing KS-like lesions under immunosuppression opens new frontiers to experimentally validate
the role immune cells play in KS development. Thus, our objective is to define the role of reduced CD4+ and
CD8+ T cell levels in persistent KSHV infection and subsequent KS pathogenesis in the marmoset NHP model.
Anti-CD4 and anti-CD8 monoclonal antibodies (mAbs) have been used to deplete T cells and induce
immunosuppression in both murine and NHP animal models, enabling study of CD4+/CD8+ T cells in controlling
replication of several viruses. To avoid any adverse responses to murine mAbs when administered into
marmosets, we will chimerize (murine-marmoset) anti-CD4/CD8 mAbs and characterize their biochemical and
pharmacokinetic properties in vitro and in mice, then we will determine the effects of antibody-mediated T cell
depletion on various immune cell populations (Aim 1). We will then challenge immunosuppressed marmosets
with KSHV.219 virus and determine the extent to which antibody-mediated depletion of CD4+ and/or CD8+ T
cells enables persistent KSHV infection and KS pathogenesis in immunocompromised marmosets (Aim 2). The
successful completion of this project will validate the common marmoset as a tool for understanding the etiology
of KS and uncover the critical role that CD4+ and/or CD8+ T cell depletion plays in allowing persistent KSHV
infection and subsequent KS pathogenesis in immunocompromised animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金